MedPath

The Utility of Hyperacetylated HMGB1 as Tumor Marker of Malignant Mesothelioma; a prospective observational study

Not Applicable
Conditions
Malignant Mesothelioma
Registration Number
JPRN-UMIN000024455
Lead Sponsor
Department of Pulmonology, Yokohama City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who refuse to participate in the study 2. Any patient found to be not applicable by an examiner

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ability of prognostic prediction and correlations with IMIG classification, existing tumor markers, and inflammatory factors of HMGB1 and its isoforms
Secondary Outcome Measures
NameTimeMethod
Ability of prognosis prediction, correlations with IMIG classification, existing tumor markers, and inflammatory factors
© Copyright 2025. All Rights Reserved by MedPath